Ngā hua rapu - André, Fabrice

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials mā Lavaud, Pernelle, Andre, Fabrice

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer mā André, Fabrice, Cortés, Javier

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy? mā Stagg, John, Andre, Fabrice, Loi, Sherene

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer mā Stefanovska, Bojana, André, Fabrice, Fromigué, Olivia

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Targeted therapies for ER+/HER2- metastatic breast cancer mā Yamamoto-Ibusuki, Mutsuko, Arnedos, Monica, André, Fabrice

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Triple-negative breast cancer: are we making headway at least? mā Arnedos, Monica, Bihan, Celine, Delaloge, Suzette, Andre, Fabrice

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy mā Ladoire, Sylvain, Enot, David, Andre, Fabrice, Zitvogel, Laurence, Kroemer, Guido

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

News from the San Antonio Breast Cancer Symposium 2018 mā Pfeiler, Georg, André, Fabrice, Janni, Wolfgang, Steger, Günther, Untch, Michael

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up? mā Curigliano, Giuseppe, Criscitiello, Carmen, Andrè, Fabrice, Colleoni, Marco, Di Leo, Angelo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The anticancer immune response: indispensable for therapeutic success? mā Zitvogel, Laurence, Apetoh, Lionel, Ghiringhelli, François, André, Fabrice, Tesniere, Antoine, Kroemer, Guido

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Clinical development of mTOR inhibitors in breast cancer mā Vicier, Cecile, Dieci, Maria Vittoria, Arnedos, Monica, Delaloge, Suzette, Viens, Patrice, Andre, Fabrice

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19–positive patients with cancer mā Scotté, Florian, Minvielle, Etienne, Mir, Olivier, André, Fabrice, Barlesi, Fabrice, Soria, Jean-Charles

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

PI3K inhibitors are finally coming of age mā Vanhaesebroeck, Bart, Perry, Matthew W.D., Brown, Jennifer R., André, Fabrice, Okkenhaug, Klaus

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

rCGH: a comprehensive array-based genomic profile platform for precision medicine mā Commo, Frederic, Guinney, Justin, Ferté, Charles, Bot, Brian, Lefebvre, Celine, Soria, Jean-Charles, André, Fabrice

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Dendritic cell–derived exosomes for cancer therapy mā Pitt, Jonathan M., André, Fabrice, Amigorena, Sebastian, Soria, Jean-Charles, Eggermont, Alexander, Kroemer, Guido, Zitvogel, Laurence

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Nuclear localization of the caspase-3-cleaved form of p73 in anoikis mā Alsafadi, Samar, Tourpin, Sophie, Bessoltane, Nadia, Salomé-Desnoulez, Sophie, Vassal, Gilles, André, Fabrice, Ahomadegbe, Jean-Charles

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies mā Jobard, Elodie, Trédan, Olivier, Postoly, Déborah, André, Fabrice, Martin, Anne-Laure, Elena-Herrmann, Bénédicte, Boyault, Sandrine

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials mā Andre, Fabrice, Broglio, Kristine, Pusztai, Lajos, Berrada, Narjiss, Mackey, John R., Nabholtz, Jean Marc, Chan, Stephen, Hortobagyi, Gabriel N.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: The case of the Institut Gustave Roussy mā Arnedos, Monica, André, Fabrice, Farace, Françoise, Lacroix, Ludovic, Besse, Benjamin, Robert, Caroline, Soria, Jean Charles, Eggermont, Alexander M.M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Evaluation of biological pathways involved in chemotherapy response in breast cancer mā Tordai, Attila, Wang, Jing, Andre, Fabrice, Liedtke, Cornelia, Yan, Kai, Sotiriou, Christos, Hortobagyi, Gabriel N, Symmans, W Fraser, Pusztai, Lajos

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa